Related Experiment Video
Updated: May 5, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
34.8K
Pharmacology: uncoupling the agony from ecstasy.
Edward M Mills1, Matthew L Banks, Jon E Sprague
1Cardiovascular Branch, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-1622, USA.
Nature
|December 4, 2003
Summary
Mice lacking the mitochondrial protein UCP-3 (uncoupling protein-3) showed reduced body temperature increases from MDMA (ecstasy). This suggests UCP-3 plays a key role in MDMA-induced hyperthermia, offering a potential therapeutic target.
Area of Science:
- Biochemistry
- Pharmacology
- Physiology
Background:
- Recreational amphetamine-type stimulant use can cause dangerous, potentially lethal, increases in body temperature (hyperthermia).
- Understanding the mechanisms behind stimulant-induced hyperthermia is crucial for public health.
- Mitochondrial uncoupling proteins are involved in thermogenesis.
Purpose of the Study:
- To investigate the role of uncoupling protein-3 (UCP-3) in MDMA-induced hyperthermia.
- To determine if UCP-3 deficiency protects against MDMA toxicity.
Main Methods:
- Utilized a mouse model deficient in the mitochondrial protein UCP-3.
- Administered MDMA (3,4-methylenedioxymethamphetamine) to wild-type and UCP-3 knockout mice.
- Monitored thermogenic responses and physiological effects.
Main Results:
- Mice lacking UCP-3 exhibited a significantly diminished thermogenic response to MDMA compared to control mice.
- UCP-3 deficient mice were protected against the toxic effects of MDMA, specifically hyperthermia.
- This indicates a critical role for UCP-3 in the development of MDMA-induced hyperthermia.
Conclusions:
- Uncoupling protein-3 is a key mediator of MDMA-induced hyperthermia.
- Targeting UCP-3 may offer a novel therapeutic strategy to mitigate the risks associated with recreational MDMA use.
- These findings address a significant public health concern related to stimulant toxicity.
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
01:20Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
01:22CNS Stimulants: Psychedelic Agents
1.1K
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.1K
01:25Analgesia and Pain Management
3.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
01:14Agonism and Antagonism: Quantification
1.4K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.4K